Skip to content

Prognostic Significance of Mutation Type and Chromosome Fragility in Fanconi Anemia

Prognostic Significance of Mutation Type and Chromosome Fragility in Fanconi Anemia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06490510
Enrollment
227
Registered
2024-07-08
Start date
2024-05-16
Completion date
2024-06-18
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fanconi Anemia

Brief summary

The goal of this observational study is to analyze the data included in the Spanish Registry of Patients with Fanconi anemia to better understand the natural history of the disease, identify genetic risk and prognostic factors, and identify potential therapeutic strategies.

Interventions

None listed

Sponsors

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* All patients in the Spanish Registry of Patients with Fanconi Anemia

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Description of the clinical evolution of the patient1 monthStudy the clinical evolution of patients with Fanconi anemia

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026